Difflam™ Oral Rinse
Difflam Oral Rinse (benzydamine hydrochloride) 0.15% w/v gargle
Difflam™ Oral Rinse is a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions of the mouth and throat. 1, 2
- 300ml bottle with measuring cap for accurate dosage
- Suitable for adults and children over 12 years1
Treat painful inflammatory conditions of the mouth and throat including:1, 2
- Pain, soreness, swelling and discomfort of the throat, including pharyngitis.
- Traumatic conditions: Pharyngitis following tonsillectomy or the use of a naso-gastric tube
- Inflammatory conditions: Pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy
- Dentistry: For use after dental operations.
Product dosage information2
Pour 15ml of Difflam™ Oral Rinse into the measuring cup. Gargle or rinse around the mouth then spit out.1
If you find Difflam™ Oral Rinse stings the inside of your mouth, it can be diluted in the measuring cup with water.2
Recommended for: Adults and children (12+ years of age)
Recommended Dosage: 15 ml every 1.5 to 3 hours
Not suitable for children aged 12 years or under.
- Difflam™ Rinse Patient Information leaflet (PIL). Accessed at www.medicines.ie. Accessed January 2024.
- Difflam™ Oral Rinse, Summary of Product Characteristics. Accessed at www.medicines.ie. Accessed January 2024.
PLEASE REFER TO THE SUMMARY OF PRODUCT CHARACTERISTICS (SmPC) FOR FULL PRESCRIBING INFORMATION
- Difflam™ Spray Patient information leaflet
- Difflam™ Spray Summary of Product Characteristics
- Difflam™ Oral Rinse Patient Information Leaflet
- Difflam™ Oral Rinse Summary of Product Characteristics
Reporting of adverse reactions:
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Website: www.hpra.ie
Adverse reactions/events should also be reported to the marketing authorisation holder at email address: pv.ireland@viatris.com or phone 0044 (0) 800 1218267.
